DNER and nut midline carcinoma: In vitro and in vivo data have suggested that CDK 4/6 inhibitors are synergistic with BET inhibitors in inhibiting NUT carcinoma growth.24 NCT05272640 hopes to evaluate the efficacy of ZEN003694 and abemaciclib.